ENTITY
GlaxoSmithKline PLC

GlaxoSmithKline PLC (GSK LN)

108
Analysis
Health CareUnited Kingdom
GlaxoSmithKline PLC operates as a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer.
more
bullishKingsoft Cloud
10 May 2020 13:33

ECM Weekly (10 May 2020) - Kingsoft Cloud, NetEase, Central China New Life, Peijia Medical, Kintor,

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. As...

Share
06 May 2020 20:17

Hindustan Unilever Placement - As Expected, Doing It Right

In my insight earlier this week, Hindustan Unilever Prospective Placement - Early Look - The US$3.6bn Overhang, I wrote about how GlaxoSmithKline...

Logo
416 Views
Share
05 May 2020 16:36

Hindustan Unilever Prospective Placement - Early Look - The US$3.6bn Overhang

GlaxoSmithKline PLC (GSK LN) owns about 5.7% of Hindustan Unilever (HUVR IN), through shares that it recently received upon the completion of...

Logo
406 Views
Share
bullishS&P 500 INDEX
12 Dec 2019 21:11

U. S. Equity Strategy: Small-Caps Closing the Gap

Major averages in the US (S&P 500, Dow, Russell 2000) and Europe (STOXX 600 & 50) each had throwbacks to their prior breakout levels last...

Logo
441 Views
Share
28 Feb 2019 04:23

Amarin Q4 2018 Conference Call--Strong Sales & High Confidence

Q4 2018 Revenues Stronger Than Pre-Announcement on January 4th: Amarin released its Q4 2018 results today and held a conference call. Results of...

Logo
689 Views
Share
x